HOME >> BIOLOGY >> NEWS
Diabetes therapies and liquid memory may develop from micro fluid research, Science researchers say

This press release is also available in Japanese.

Polymer solutions pulsing through miniaturized plumbing may control implanted drug delivery devices and provide memory for liquid computers, according to a new study.

The researchers created two small-scale fluid drive devices, one for flow control and the other for fluidic memory, that rely on the special behavior of polymer liquids to function. These findings are described in the 09 May issue of the journal Science, published by the American Association for the Advancement of Science (AAAS).

"One option for this research would be an artificial pancreas for patients with diabetes. The device could measure glucose levels and dispense appropriate amounts of insulin," said Stephen Quake, an author from the California Institute of Technology in Pasadena, California.

Implantable devices employing this technology may eventually monitor aspects of human physiology from the inside and dole out drugs accordingly, explained Quake.

"Although we have only built pilot devices, there may be some practical drug delivery applications for them," said Alex Groisman, the first author on the paper and a researcher from the University of California-San Diego in La Jolla, California.

Groisman used the pharmaceutical application model to explain the operation of this new generation of fluid contraptions.

"Imagine an implanted pill with an inflatable chamber to hold a drug. If you connect this reservoir to the drug's drop-off spot in the body with a microfluidic channel, you can achieve relatively constant flow of medicine despite decreases in pressure," said Groisman.

This consistency of flow, despite changing pressure, is a special feature of this new device called a "flux stabilizer."

"You could discharge 90 percent of your medicine without an intolerable decr
'"/>

Contact: Lisa Onaga
lonaga@aaas.org
202-326-7088
American Association for the Advancement of Science
8-May-2003


Page: 1 2 3

Related biology news :

1. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
2. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
3. Joslin Diabetes Center launches research section on developmental and stem cell biology
4. Joslin Diabetes Center releases new low impact exercise video
5. As obesity skyrockets, Joslin Diabetes Center urges action to stem the tide of type 2 diabetes
6. Diabetes drug may be new tool in treating breast cancer
7. Diabetes in the elderly linked to fewer cellular power plants
8. Diabetes tied to altering of the hearts circadian clock
9. Bacteria From Gum Infections Associated With Diabetes, Chronic Lung Disease, UB Studies Find
10. New Findings On Receptor Regulation May Lead To Better Drugs For Diabetes
11. Researchers Identify And Isolate First Gene For A Form Of Insulin-Dependent Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/11/2019)... ... July 11, 2019 , ... ... first on-site Legionella DNA test, today announced a partnership with LiquiTech, a ... , Through this strategic partnership, LiquiTech will integrate Spartan’s innovative environmental DNA ...
(Date:7/5/2019)... VIEW, Calif. (PRWEB) , ... July 05, 2019 ... ... partnering with Microsoft to bring its patented Tractus™ Platform to governments around the ... will bring cutting edge technology and point of care solutions to operating theatres ...
(Date:6/19/2019)... (PRWEB) , ... June 19, 2019 , ... Dahryn Trivedi, ... physicochemical properties of Cefazolin Sodium, antibiotic which can prove to be beneficial for treating ... 519% increase in residue amount , Over 68% decrease in weight ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff has been named ... as the 2019 Innovative Product of the Year which highlights cutting-edge advancements and ... Sensors Expo & Conference 2019, held this week in San Jose, ...
(Date:6/26/2019)... ... , ... Alice Branton today released research results from preclinical trials on the ... can prove to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... size , Over 142% increase in particle size , Over ...
(Date:6/18/2019)... ... 18, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human ... FDA for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. ... knee. This IND is the first of several planned clinical trials which will ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... network with the appointment of Biofeedback Tech Ltd as its authorised ... an essential part of many therapeutic treatments and clinical assessment protocols to treat ...
Breaking Biology Technology:
Cached News: